Polygenic risk factors for comorbid diagnoses in individuals with substance use disorders: A phenome-wide survival analysis

Read full text
Authors: Peter B. Barr, Zoe E. Neale, Tim B. Bigdeli, Chris Chatzinakos, Philip D. Harvey, Roseann E. Peterson, Jacquelyn L. Meyers
Cited by: 1
References: 59

Abstract

OBJECTIVE: Persons with substance use disorders (SUD) often suffer from additional comorbidities. Researchers have explored this overlap via phenome-wide association studies (PheWASs). However, PheWASs are largely cross-sectional, limiting our understanding of whether diagnoses predate the development of an SUD. We characterize whether polygenic scores (PGSs) are associated with time to comorbid diagnoses in electronic health records (EHR) after the first documented SUD diagnosis. METHODS: = 21,357), whether PGS for alcohol use disorders, cannabis use disorders, depression, externalizing, posttraumatic stress disorder, and schizophrenia were associated with subsequent diagnoses via a phenome-wide survival analysis. RESULTS: Multiple SDoHs were associated with lifetime SUD diagnosis, with annual household income having the largest overall associations (e.g.

Fields of Study & Subjects

Substance Abuse Treatment and Outcomes Genetic Associations and Epidemiology Mental Health Research Topics

Publication details

Journal / source
Psychological Medicine
Publisher
Cambridge University Press (CUP)
Volume
56
Pages
e174–e174
Publication date
1 January 2026
Language
EN